Thework demonstrates the capability of [64Cu]-NOTA-anti-CD8PET to measure the number of CD8+ T lymphocytes in both the peripheraland tumor-infiltrating regions of brain tumors.163. This evidence concerns the gene CD8A and neoplasm.